The current P/S ratio of 5.41 indicates a premium valuation that likely stems from the company's asset-light licensing model rather than its hardware sales. This valuation appears to imply that the market expects sustained margin expansion from the high-margin DMR and revenue-sharing segments, though investors should monitor whether these multiples are sustainable if box office performance remains inconsistent.

The low ROIC relative to historical peaks suggests that the company is not yet generating sufficient returns to justify its capital base during periods of lower box office activity. This trend warrants further investigation into whether the current investment in new technology initiatives will eventually drive a structural improvement in capital efficiency or if the business model remains permanently tethered to the volatility of theatrical tentpoles.

The elevated DSO of 137 days suggests that IMAX may be providing significant credit to exhibitors, which ties up liquidity and creates a mismatch between revenue recognition and actual cash collection. This inefficiency appears to be a structural feature of the revenue-sharing model, requiring careful monitoring of counterparty risk in key growth regions like China.

The interest coverage ratio of 5.25 in 2026Q1 suggests that debt service remains manageable, even during periods of revenue contraction. This conservative capital structure appears to be a deliberate strategy to maintain operational flexibility, allowing the company to navigate periods of low box office performance without the immediate threat of covenant breaches or liquidity crises.